China NMPA Product Recall - Angioguard RX Emboli Capture Guidewire System
China NMPA product recall for Angioguard RX Emboli Capture Guidewire System by Cordis Corporation published March 27, 2023. Recall level: Level 1 Recall. The National Medical Products Administration (NMPA) issued an alert on March 27, 2023, regarding a v
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Angioguard RX Emboli Capture Guidewire System by Cordis Corporation published March 27, 2023. Recall level: Level 1 Recall. The National Medical Products Administration (NMPA) issued an alert on March 27, 2023, regarding a v
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Cordis CorporationInspection Date
Unknown Date
Product Type
ID: 4d6545cd-46da-46d2-af6d-a8795cca8346
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox